A B C D E F G H I J K L M N O P Q R S T U V W X Y Z

Lapatinib Impurity 21 - Request Quote

Picture of Lapatinib Impurity 21

Lapatinib Impurity 21

SZ CAT No: SZ-L036029
CAS No
NA
Mol.F.
C30H26ClFN4O5S
Mol.Wt.
609.1
Inv. Status
In Stock

Chemical Name :

Shipping Temperature :

HSN Code :

Country of Origin :

Smiles :

Hazard Statement:

Usage Note:

Lapatinib Impurity 21 is chemically N-((5-(4-((3-Chloro-4-((3-fluorobenzyl)oxy)phenyl)amino)quinazolin-6-yl)furan-2-yl)methyl)-N-(2-(methylsulfonyl)ethyl)formamide. Lapatinib Impurity 21 is supplied with detailed characterization data compliant with regulatory guideline. Lapatinib Impurity 21 can be used for the analytical method development, method validation (AMV), Quality Controlled (QC) application for Abbreviated New Drug Application (ANDA) or during commercial production of Lapatinib.

The product can be used as reference standards and further traceability against pharmacopeial standards (USP or EP) can be provided based on feasibility. SynZeal products are for analytical purpose only and not for human use.

Applications & Regulatory Use Cases

buy high quality Lapatinib Impurity 21

Purchase Lapatinib Impurity 21

Lapatinib Impurity 21 suppliers

Lapatinib Impurity 21 manufacturers

Lapatinib Impurity 21 price

Order Lapatinib Impurity 21

Enquire Lapatinib Impurity 21

Lapatinib Impurity 21 cost

Lapatinib Impurity 21 Supplier

Lapatinib Impurity 21 Distributor

Lapatinib Impurity 21 for Method Validation

Lapatinib Reference Standard

Lapatinib Impurity 21 for ANDA Filing

Lapatinib Impurity 21 for Forced Degradation Studies

Lapatinib Impurity 21 Identification Standards

Lapatinib Impurity 21 for DMF Filing

ℹ️

Disclaimer

SynZeal product information given on this website is as per the existing understanding while publishing the details on website. The customer is responsible for assessing the accuracy of the information at the time of actual purchase.

SynZeal will update these details as per new developments or findings in product specifications without further notice.

,